CRT 2025
Spotlight
Radiation Protection
James B. Hermiller, MD, FACC, MSCAI
Director Interventional Cardiology
St. Vincent Medical Group
Indianapolis, Indiana, United States
No relationships to disclose
Wah Wah Htun, MD
Chief of Cardiology
Gundersen Health
La crosse , Wisconsin, United States
No relationships to disclose
Dean J. Kereiakes, MD, FACC, MSCAI
Chairman, The Christ Hospital Heart and Vascular Institute; Medical Director, The Christ Hospital Research Institute; Professor of Clinical Medicine, The Ohio State University
The Christ Hospital Health Network
Cincinnati, Ohio, United States
No relationships to disclose
Morton J. Kern, MD, MSCAI, FACC, FAHA
Interventional Cardiologist
VA Long Beach Health Care System
Long Beach, California, United States
No relationships to disclose
Ajar Kochar, MD, MHS
Program Director
Brigham and Women's Hospital/Harvard Medical School
CHESTNUT HILL, Massachusetts, United States
Disclosure information not submitted.
Ryan D. Madder, MD
Section Chief of Interventional Cardiology & Director of Cardiac Cath Lab
Corewell Health
Ada, Michigan, United States
No relationships to disclose
Kenneth Rosenfield, MD, MHCDS
section head, vascular medicine and intervention
Massachusetts General Hospital
boston, Massachusetts, United States
Disclosure(s): Abbott Vasular: Consulting Fees (e.g., advisory boards) (Ongoing); Akura: Stock-privately held company (Ongoing); Angiodynamics: Consulting Fees (e.g., advisory boards) (Ongoing); Boston Scientific: Consultant (Ongoing), Grant/Research Support (Ongoing); Contego: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Cordis: Consulting Fees (e.g., advisory boards) (Ongoing); Fastwave: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Imperative Care: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Innova Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Inspire MD: Stock-privately held company (Ongoing); Johnson and Johnson: Consulting Fees (e.g., advisory boards) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing); MiRus: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); NAMSA: Consulting Fees (e.g., advisory boards) (Ongoing); Neptune: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing); Radiaction: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Sonovascular: Stock-privately held company (Ongoing); Thrombolex: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vantis Vascular: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Vasorum: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); Viz.ai: Consulting Fees (e.g., advisory boards) (Ongoing), Stock-privately held company (Ongoing); VuMedi: Stock-privately held company (Ongoing)
Eric A. Secemsky, MD, MSc
Director of Vascular Intervention
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
No relationships to disclose